Zurzuvae

First oral medicine for postpartum depression approved

7 August 2023 | By Catherine Eckford (European Pharmaceutical Review)

The first approved oral treatment that provides rapid symptomatic improvement in postpartum depression (PPD) is expected to be commercially available in the fourth quarter of 2023.